| Colin Elliott Wolslegel, DO | |
|
907 Georgiana St, Port Angeles, WA 98362-3911 | |
| (360) 565-0999 | |
| (360) 565-9251 |
| Full Name | Colin Elliott Wolslegel |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 13 Years |
| Location | 907 Georgiana St, Port Angeles, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982990297 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | OP60738862 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Olympic Medical Center | Port angeles, WA | Hospital |
| Baptist Memorial Hospital Desoto | Southaven, MS | Hospital |
| Forks Community Hospital | Forks, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Olympic Medical Physicians | 9537172358 | 113 |
News Archive
The study that aimed to understand if the consumption of artificial sweeteners is linked with adverse long term effects on weight and heart disease, was published in the Canadian Medical Association Journal (CMAJ), today.
NovaBay Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing non-antibiotic, topical antimicrobial products, today announced it has completed enrollment of patients in its global Phase 2b viral conjunctivitis trial, BAYnovation.
Omeros Corporation today announced that it has submitted to the U.S. Food and Drug Administration (FDA) an investigational new drug (IND) application to initiate the Phase 2 clinical program for OMS721, the company's lead human monoclonal antibody targeting mannan-binding lectin‑associated serine protease-2 (MASP-2), the key regulator of the lectin pathway of the immune system.
Radiation therapy after surgery for men with prostate cancer lessens the chance of the cancer coming back, regardless of whether the radiation was administered immediately after surgery or after the cancer recurred, according to a new study in the June 2004 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.
A heartier appetite is linked to more rapid infant growth and to genetic predisposition to obesity, according to two papers published in JAMA Pediatrics today (Monday).
› Verified 1 days ago
| Entity Name | Olympic Medical Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427081967 PECOS PAC ID: 9537172358 Enrollment ID: O20060721000246 |
News Archive
The study that aimed to understand if the consumption of artificial sweeteners is linked with adverse long term effects on weight and heart disease, was published in the Canadian Medical Association Journal (CMAJ), today.
NovaBay Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing non-antibiotic, topical antimicrobial products, today announced it has completed enrollment of patients in its global Phase 2b viral conjunctivitis trial, BAYnovation.
Omeros Corporation today announced that it has submitted to the U.S. Food and Drug Administration (FDA) an investigational new drug (IND) application to initiate the Phase 2 clinical program for OMS721, the company's lead human monoclonal antibody targeting mannan-binding lectin‑associated serine protease-2 (MASP-2), the key regulator of the lectin pathway of the immune system.
Radiation therapy after surgery for men with prostate cancer lessens the chance of the cancer coming back, regardless of whether the radiation was administered immediately after surgery or after the cancer recurred, according to a new study in the June 2004 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.
A heartier appetite is linked to more rapid infant growth and to genetic predisposition to obesity, according to two papers published in JAMA Pediatrics today (Monday).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Colin Elliott Wolslegel, DO Po Box 850, Port Angeles, WA 98362-0146 Ph: (360) 565-9237 | Colin Elliott Wolslegel, DO 907 Georgiana St, Port Angeles, WA 98362-3911 Ph: (360) 565-0999 |
News Archive
The study that aimed to understand if the consumption of artificial sweeteners is linked with adverse long term effects on weight and heart disease, was published in the Canadian Medical Association Journal (CMAJ), today.
NovaBay Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing non-antibiotic, topical antimicrobial products, today announced it has completed enrollment of patients in its global Phase 2b viral conjunctivitis trial, BAYnovation.
Omeros Corporation today announced that it has submitted to the U.S. Food and Drug Administration (FDA) an investigational new drug (IND) application to initiate the Phase 2 clinical program for OMS721, the company's lead human monoclonal antibody targeting mannan-binding lectin‑associated serine protease-2 (MASP-2), the key regulator of the lectin pathway of the immune system.
Radiation therapy after surgery for men with prostate cancer lessens the chance of the cancer coming back, regardless of whether the radiation was administered immediately after surgery or after the cancer recurred, according to a new study in the June 2004 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.
A heartier appetite is linked to more rapid infant growth and to genetic predisposition to obesity, according to two papers published in JAMA Pediatrics today (Monday).
› Verified 1 days ago
Zina Hajduczok, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 907 Georgiana St, Port Angeles, WA 98362 Phone: 360-565-0999 Fax: 360-565-9251 | |
Dr. Aleksey Tagintsev, DO Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 939 Caroline St, Port Angeles, WA 98362 Phone: 360-417-7000 | |
Mr. Evgeny A Bistrika, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 939 Caroline St, Port Angeles, WA 98362 Phone: 360-417-7000 Fax: 360-417-7318 | |
Dr. David B Bayne, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 907 Georgiana St, Port Angeles, WA 98362 Phone: 360-565-0999 Fax: 360-565-0901 | |
Paul E Pederson, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 939 Caroline St, Port Angeles, WA 98362 Phone: 360-417-7000 Fax: 360-417-7318 | |
Christopher S Morley, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 939 Caroline St, Port Angeles, WA 98362 Phone: 360-417-7000 Fax: 360-565-9241 | |
Dr. Amir Kazerouninia, M.D. PH.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 907 Georgiana St, Port Angeles, WA 98362 Phone: 360-565-0999 Fax: 360-565-0901 |